Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 15/3/2021
SIETES contiene 93212 citas

 
 
 1 a 20 de 85 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Tisdale JE, Chung MK, Campbell KB, Hammadah M, Joglar JA, Rajagopalan B, On behalf of the American Heart Association Clinical Pharmacology Committee of the Council on Clinical Cardiology and Council on Cardiovascular and Stroke Nursing. Drug-induced arrhythmias. A scientific statement from the American Heart Association. Circulation 2020;142:16 de septiembre. [Ref.ID 103712]
2.Tiene citas relacionadas Cita con resumen
Öngür D. Dopamine dysfunction in schizophrenia and bipolar disorder - Never the twain shall meet?. JAMA Psychiatry 2017:11 de octubre. [Ref.ID 102090]
3.Tiene citas relacionadas Cita con resumen
Jauhar S, Nour MM, Veronese M, Rogdaki M, Bonoldi I, Azis M, Turkheimer F, McGuire P, Young AH, Howes OD. A tests of the transdiagnostic dopamine hypothesis of psychosis using positron emission tomographic imaging in bipolar affective disorder and schizophrenia. JAMA Psychiatry 2017:11 de octubre. [Ref.ID 102089]
4. Cita con resumen
Anónimo. Lévosimendan et décompensation d'une insuffisance cardiaque. Prescrire 2017;37:245-7. [Ref.ID 101528]
5.Enlace a cita original Cita con resumen
Crispo JAG, Fortin Y, Thibault DP, Emons M, Bjerre LM, Kohen DE, Perez-Lloret S, Mattison DR, Willis AW, Krewski D. Trends in inpatient antiparkinson drug use in the USA, 2001-2012. Eur J Clin Pharmacol 2015;71:1011-9. [Ref.ID 99381]
6. Cita con resumen
Anónimo. Rotigotine transdermique dans les jambes sans repos: troubles compulsifs. Prescrire 2014;34:351. [Ref.ID 97561]
7. Cita con resumen
Llop R. Fármacos y alopecia. Formación Médica Continuada en Atención Primaria 2014;21:293-7. [Ref.ID 97542]
8. Cita con resumen
Connolly BS, Lang AE. Pharmacological treatment of Parkinson disease: a review. JAMA 2014;311:1670-83. [Ref.ID 97495]
9.
Chen HH, Anstrom KJ, Givertz MM, Stevenson LW, Semigran J, Goldsmith SR, BArt BA, Bull DA, Stehlik J, LeWinter MM, Konstam MA, Huggins GS, Rouleau JL, O'Meara E, Tang WHW, Starling RC, Butler J, Deswal A, Felker M, O'Connor CM, Bonita RE, Margulies KB, Cappola TP, Ofili EO, Mann DL, Dávila-Román VG, McNulty SE, Borlaug BA, Velazquez EJ, Lee KL, Shah MR, Hernandez AF, Braunwald E, Redfield MM, for the NHLBI Heart Failure Clinical Research Network. Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial. JAMA 2013;310:2533-43. [Ref.ID 96674]
10. Cita con resumen
Anónimo. Vasopressors and inotropes. Med Lett Drugs Ther 2011;53:90-2. [Ref.ID 91825]
11. Cita con resumen
Rouve N, Bagheri H, Telmon N, Pathak A, Franchitto N, Schmitt L, Rougé D, Lapeyre-Mestre M, Montastruc J-L, The French Association of Regional PharmacoVigilance Centres. Prescribed drugs and violence: a case/noncase study in the French PharmacoVigilance Database. Eur J Clin Pharmacol 2011;67:1189-98. [Ref.ID 91779]
12.
Anónimo. Inssufisance cardiaque aiguë avec dyspnée: traitement initial. Prescrire 2010;30:911-6. [Ref.ID 89740]
13.
Brennan KA, Genever RW. Managing Parkinson's disease during surgery. BMJ 2010;341:990-3. [Ref.ID 89620]
14.Tiene citas relacionadas
Levy JH. Treating shock - Old drugs, new ideas. N Engl J Med 2010;362:841-3. [Ref.ID 87960]
15.Tiene citas relacionadas Cita con resumen
De Backer D, Biston P, Devriendt J, Madl C, Chochrad D, Aldecoa C, Brasseur A, Defrance P, Gottignies P, Vincent JL, for the SOAP Ii Investigators. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med 2010;362:779-89. [Ref.ID 87955]
16.Enlace a cita original
Grosset DG, Macphee GJA, Nairn M, on behalf of the Guideline Development Group. Diagnosis and pharmacological management of Parkinson's disease: summary of SIGN guidelines. BMJ 2010;340:206-9. [Ref.ID 87708]
18. Cita con resumen
Volkow ND, Fowler JS, Logan J, Alexoff D, Zhu W, Telang F, Wang GJ, Jayne M, Hooker JM, Wong C, Hubbard B, Carter P, Warner D, King P, Shea C, Xu Y, Muench L, Apelskog-Torres K. Effects of modafinil on dopamine and dopamine transporters in the male human brain. Clinical implications. JAMA 2009;301:1148-54. [Ref.ID 85497]
19. Cita con resumen
Ferré S. La cafeína en la enfermedad del Parkinson. Med Clin (Barc) 2008;131:710-5. [Ref.ID 84616]
20.
Miselli M. Rotigotina. Informazioni sui Farmaci 2008;32:33-4. [Ref.ID 83701]
Seleccionar todas
 
 1 a 20 de 85 siguiente >>